Skip to main content

Diagnostic Imaging in Cancer Therapy with Magnetic Nanoparticles

  • Conference paper
Magnetic Particle Imaging

Abstract

The unfavorable application-to-tumor-dose-ratio is a drawback of conventional systemic chemotherapy, implying an often insufficient drug dose in the tumor being associated with severe side effects for the patient. The use of chemotherapeutics bound to magnetic nanoparticles offers several advantages. On the one hand it is possible to concentrate the chemotherapeutics in the tumor region by the use of magnetic fields, like it is done in Magnetic Drug Targeting (MDT). On the other hand magnetic particles can serve as contrast agent for magnetic resonance imaging (MRI) that is bound to the therapeutics. Hence, the particles possibly are opening an insight into drug distribution in the tumor region directly after administration.

Another important factor for a successful MDT-application is detailed knowledge about tumor vascularization.

In this pilot study we investigated vascularization and size of an tumor in an experimental in vivo tumor model via flat-panel angiography and DYNA-CT before MDT and the particle distribution with MRI after MDT.

We could show that the tumor could be displayed by MRI and DYNA-CT before and after MDT. Flat panel angiography revealed clearly the pathological tumor vascularization before MDT, while MRI imaging afterwards displayed the tumor as well as the particle distribution in the tumor.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Morrison, K.E.: Whole-genome sequencing informs treatment: personalized medicine takes another step forward. Clin. Chem. 57(12), 1638–1640 (2011)

    Article  Google Scholar 

  2. Natoli, G., Capalbo, C.: The end of the beginning of personalized medicine. Ann. Oncol. 22(12), 2695 (2011)

    Article  Google Scholar 

  3. Chiang, A., Million, R.P.: Personalized medicine in oncology: next generation. Nat. Rev. Drug. Discov. 10(12), 895–896 (2011)

    Article  Google Scholar 

  4. Corless, C.L.: Personalized cancer diagnostics. Science 334(6060), 1217–1218 (2011)

    Article  Google Scholar 

  5. Degoma, E.M., et al.: Personalized vascular medicine: individualizing drug therapy. Vasc. Med. 16(5), 391–404 (2011)

    Article  Google Scholar 

  6. Shapiro, S.D.: Merging personalized medicine and biology of aging in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 184(8), 864–866 (2011)

    Article  Google Scholar 

  7. Zarco, M., Vess, T., Ginsburg, G.: The oral microbiome in health and disease and the potential impact on personalized dental medicine. Oral. Dis (2011)

    Google Scholar 

  8. Wong, E.H., et al.: Toward personalized medicine in the neuropsychiatric field. Int. Rev. Neurobiol. 101, 329–349 (2011)

    Google Scholar 

  9. Kelkar, S.S., Reineke, T.M.: Theranostics: combining imaging and therapy. Bioconjug. Chem. 22(10), 1879–1903 (2011)

    Article  Google Scholar 

  10. Cole, A.J., Yang, V.C., David, A.E.: Cancer theranostics: the rise of targeted magnetic nanoparticles. Trends Biotechnol. 29(7), 323–332 (2011)

    Article  Google Scholar 

  11. Alexiou, C., et al.: Locoregional cancer treatment with magnetic drug targeting. Cancer Research 60(23), 6641–6648 (2000)

    Google Scholar 

  12. Alexiou, C., et al.: Magnetic drug targeting - Biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment. J. Drug Target 11(3), 139–149 (2003)

    Article  MathSciNet  Google Scholar 

  13. Jurgons, R., et al.: Drug loaded magnetic nanoparticles for cancer therapy. Journal of Physics-Condensed Matter 18(38), S2893–S2902 (2006)

    Article  Google Scholar 

  14. Lyer, S., et al.: Visualization of Tumor Regression after Local Chemotherapy with Magnetic Nanoparticles. Anticancer Research 28(6B), 4079–4080 (2008)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stefan Lyer .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag GmbH Berlin Heidelberg

About this paper

Cite this paper

Lyer, S. et al. (2012). Diagnostic Imaging in Cancer Therapy with Magnetic Nanoparticles. In: Buzug, T., Borgert, J. (eds) Magnetic Particle Imaging. Springer Proceedings in Physics, vol 140. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-24133-8_32

Download citation

Publish with us

Policies and ethics